Phosphorus (as Phosphate) (Pi)

Phosphorus, circulating primarily as inorganic phosphate (Pi), is a vital mineral essential for bone health, cellular energy transfer via ATP, and the structural integrity of cell membranes and nucleic acids (https://ods.od.nih.gov/factsheets/Phosphorus-HealthProfessional/). Its concentration in the blood is tightly regulated by the interplay between the parathyroid glands, kidneys, and bone, mediated by hormones such as parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) (https://www.ncbi.nlm.nih.gov/books/NBK493175/). In clinical settings, blood phosphorus is not a protein target but rather a critical metabolite and biomarker; however, it is the direct pharmacological objective for phosphate-binding drugs. Abnormally high levels, known as hyperphosphatemia, are common in patients with chronic kidney disease and are strongly associated with increased cardiovascular mortality due to vascular calcification. Conversely, hypophosphatemia can lead to muscle weakness, respiratory failure, and metabolic bone diseases like rickets or osteomalacia. Therapeutic management focuses on dietary restriction and the use of binders to sequester phosphate in the gut, as well as emerging therapies targeting the sodium-phosphate cotransporters (NPT2) to modulate renal and intestinal handling of the ion.

Other names

Serum phosphorusInorganic phosphateOrthophosphateBlood phosphateSerum P

Phosphate binders act by physically sequestering dietary phosphate within the gastrointestinal lumen to form insoluble complexes that are excreted in the feces, thereby preventing systemic absorption and reducing serum phosphate levels (https://www.ncbi.nlm.nih.gov/books/NBK493175/).